[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-ORKA":3,"homepage-market-summary":31,"stock-news-ORKA":173},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"ORKA","2026-10-07",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Oruka Therapeutics, Inc. Common Stock","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Oruka Therapeutics Inc a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its programs are to treat and potentially modify disease by targeting mechanisms with efficacy and safety involved in disease pathology and the activity of pathogenic tissue-resident memory T cells (TRMs). Its program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. Its co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A\u002FF) for the treatment of PsO, hidradenitis suppurativa (HS), psoriatic arthritis (PsA), and other conditions.","68","Menlo Park, CA",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},79.5,79.01,81.395,78.52,80.18,-0.68,-0.85,809883.029617,15135,79.6955,115.515,20.25,962003.4345631714,62.2,7335,{"status":32,"indices":33,"watchlist":76,"sectors":98,"benchmarks":153},"success",[34,41,48,55,61,68],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":14,"sparkline":40,"date":5},"SPX","S&P 500",7801.77,-17.16,-0.22,"0.0,13.9 2.3,10.5 4.6,12.4 6.9,14.2 9.3,16.0 11.6,11.5 13.9,10.8 16.2,4.8 18.5,4.8 20.8,7.9 23.2,8.0 25.5,6.0 27.8,9.1 30.1,9.8 32.4,10.8 34.7,10.0 37.1,7.0 39.4,4.4 41.7,2.0 44.0,2.9",{"symbol":42,"name":43,"price":44,"change":45,"pct_change":46,"is_up":14,"sparkline":47,"date":5},"NDX","NASDAQ 100",31160.08,-64.4,-0.21,"0.0,15.0 2.3,13.4 4.6,14.8 6.9,16.0 9.3,16.0 11.6,12.9 13.9,11.7 16.2,6.5 18.5,5.0 20.8,6.6 23.2,6.6 25.5,5.8 27.8,7.8 30.1,7.4 32.4,7.0 34.7,6.4 37.1,4.6 39.4,2.9 41.7,2.0 44.0,2.4",{"symbol":49,"name":50,"price":51,"change":52,"pct_change":53,"is_up":14,"sparkline":54,"date":5},"DJI","DOW JONES",51180,-341,-0.66,"0.0,6.3 2.3,2.0 4.6,3.3 6.9,6.0 9.3,11.3 11.6,8.7 13.9,9.5 16.2,6.4 18.5,8.0 20.8,10.9 23.2,12.3 25.5,8.2 27.8,11.2 30.1,12.3 32.4,16.0 34.7,15.8 37.1,13.7 39.4,13.0 41.7,10.8 44.0,13.7",{"symbol":56,"name":57,"price":58,"change":59,"pct_change":39,"is_up":14,"sparkline":60,"date":5},"COMP","NASDAQ Composite",27538.69,-61.2,"0.0,15.1 2.3,12.9 4.6,14.2 6.9,16.0 9.3,16.0 11.6,12.2 13.9,11.3 16.2,6.1 18.5,5.1 20.8,7.7 23.2,7.7 25.5,6.6 27.8,8.7 30.1,8.9 32.4,8.4 34.7,8.3 37.1,5.5 39.4,3.1 41.7,2.0 44.0,2.5",{"symbol":62,"name":63,"price":64,"change":65,"pct_change":66,"is_up":14,"sparkline":67,"date":5},"RUT","RUSSELL 2000",2777,-36.4,-1.29,"0.0,3.5 2.3,2.0 4.6,4.2 6.9,6.7 9.3,8.2 11.6,6.3 13.9,8.0 16.2,6.1 18.5,4.1 20.8,10.7 23.2,11.0 25.5,10.7 27.8,13.1 30.1,14.4 32.4,15.8 34.7,14.3 37.1,11.2 39.4,8.9 41.7,11.4 44.0,16.0",{"symbol":69,"name":70,"price":71,"change":72,"pct_change":73,"is_up":74,"sparkline":75,"date":5},"VIX","CBOE VIX",15.08,0.07,0.47,true,"0.0,2.0 2.3,9.7 4.6,4.9 6.9,4.5 9.3,2.5 11.6,11.3 13.9,13.7 16.2,13.5 18.5,16.0 20.8,12.3 23.2,10.4 25.5,13.5 27.8,8.8 30.1,8.9 32.4,7.8 34.7,7.6 37.1,11.8 39.4,10.9 41.7,12.9 44.0,12.6",[77,84,91],{"symbol":78,"name":79,"price":80,"change":81,"pct_change":82,"is_up":14,"sparkline":83,"date":5},"NVDA","NVIDIA Corp",237.36,-1.88,-0.79,"0.0,16.0 7.3,14.6 14.7,11.8 22.0,8.2 29.3,2.4 36.7,2.0 44.0,4.2",{"symbol":85,"name":86,"price":87,"change":88,"pct_change":89,"is_up":74,"sparkline":90,"date":5},"AAPL","Apple Inc",336.67,3.04,0.91,"0.0,16.0 7.3,9.0 14.7,14.2 22.0,7.7 29.3,9.3 36.7,7.9 44.0,2.0",{"symbol":92,"name":93,"price":94,"change":95,"pct_change":96,"is_up":14,"sparkline":97,"date":5},"TSLA","Tesla Inc",377.75,-2.93,-0.77,"0.0,16.0 7.3,15.0 14.7,15.4 22.0,7.1 29.3,3.0 36.7,2.0 44.0,3.5",[99,104,109,114,119,124,129,134,139,143,148],{"name":100,"etf":101,"change":102,"price":103,"is_up":14},"Technology","XLK",-0.3,201.39,{"name":105,"etf":106,"change":107,"price":108,"is_up":14},"Financials","XLF",-0.48,53.75,{"name":110,"etf":111,"change":112,"price":113,"is_up":74},"Healthcare","XLV",1.03,168.81,{"name":115,"etf":116,"change":117,"price":118,"is_up":14},"Consumer Cycl","XLY",-0.32,111.36,{"name":120,"etf":121,"change":122,"price":123,"is_up":14},"Consumer Staples","XLP",-0.12,81.7,{"name":125,"etf":126,"change":127,"price":128,"is_up":14},"Energy","XLE",-0.58,63.38,{"name":130,"etf":131,"change":132,"price":133,"is_up":14},"Industrials","XLI",-2.18,167.84,{"name":135,"etf":136,"change":137,"price":138,"is_up":14},"Materials","XLB",-1.51,48.98,{"name":140,"etf":141,"change":66,"price":142,"is_up":14},"Real Estate","XLRE",40.57,{"name":144,"etf":145,"change":146,"price":147,"is_up":14},"Utilities","XLU",-0.02,41.15,{"name":149,"etf":150,"change":151,"price":152,"is_up":14},"Comm Services","XLC",-0.35,111.26,[154,159,164,169],{"ticker":155,"name":156,"price":157,"change":158,"is_up":14},"SPY","SPDR S&P 500 ETF",777.22,-0.24,{"ticker":160,"name":161,"price":162,"change":163,"is_up":14},"QQQ","Invesco QQQ Trust",757.73,-0.25,{"ticker":165,"name":166,"price":167,"change":168,"is_up":14},"DIA","SPDR Dow Jones ETF",511.02,-0.69,{"ticker":170,"name":171,"price":172,"change":66,"is_up":14},"IWM","iShares Russell 2000",277.7,{"ticker":4,"count":174,"articles":175},13,[176,182,188,194,200,205,211,216,222,227,232,238,244],{"title":177,"link":178,"pubDate":179,"description":180,"source":181},"ORKA Stock Down 5% Despite Positive Week 28 Psoriasis Efficacy Data - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMijwFBVV95cUxPTWlLYTdjamYxd2FFSVlvcXVJa19WQUwyU1hHX1dOemJYMURnYkhCUXJWUUdjdUJxR05sLWhxUVFCaFJJcUZEM0FDMUlnMXlidzNabFlFMmJPZDc3OGtTT3FCSkNRejB5dVRZNFAtU3VCX292T1JNVjVrekY1X1R2Z00zc3Q0dVRHQ2tFRVFMdw?oc=5","Thu, 24 Sep 2026 07:00:00 GMT","ORKA Stock Down 5% Despite Positive Week 28 Psoriasis Efficacy Data Yahoo Finance","Yahoo Finance",{"title":183,"link":184,"pubDate":185,"description":186,"source":187},"25,000 shares from a stock-option exercise are proposed for sale at Oruka Therapeutics (NASDAQ: ORKA). - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMioAFBVV95cUxPODVzdzRINHBmOHdVZWZRWXZQODdCVmlzcVlqVksxVmo3MnFGSFdfSWhLMllLXzRNNHBCZXgtVjBCRXliMXVSYjU1NmVZa3hGSzhsdmdzOTA2cS1NbV9QR01fbl9UY20zckk3SWZJTThoMU5zN0lwc21uMTQybDZsLUwta3JXLV91X1JSU0F2SUx0ZWxRSGZuUFFDWjExbThK?oc=5","Thu, 01 Oct 2026 20:23:13 GMT","25,000 shares from a stock-option exercise are proposed for sale at Oruka Therapeutics (NASDAQ: ORKA). Stock Titan","Stock Titan",{"title":189,"link":190,"pubDate":191,"description":192,"source":193},"How Investors Are Reacting To Oruka Therapeutics (ORKA) Positive Psoriasis Trial Results - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Thu, 01 Oct 2026 00:23:20 GMT","How Investors Are Reacting To Oruka Therapeutics (ORKA) Positive Psoriasis Trial Results Simply Wall Street","Simply Wall Street",{"title":195,"link":196,"pubDate":197,"description":198,"source":199},"Understanding Momentum Shifts in (ORKA) - Stock Traders Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiugFBVV95cUxQNzdUMmJBOGE2WjI2bU9ONlJxTG1DaGNWWU5ndjFrY3YxWDJfTUhfMl91UVRnUHdFYXdTdTNQMXlZVkVOSmF1azV4XzFBUVJQYzJuNmhqTnJybDNveTRvbDg4REpvTzJ5dVNsWDR6YlVMaGllOWxHM0drbk9iLUt0M1VQNXA2dUtzZ0hHbW44YmRsTGVZZHdyNWtEUUhkRUdJck1RN3FKN1R2NV9rZXNZem16SWsyNGVHbGc?oc=5","Mon, 28 Sep 2026 04:34:02 GMT","Understanding Momentum Shifts in (ORKA) Stock Traders Daily","Stock Traders Daily",{"title":201,"link":202,"pubDate":179,"description":203,"source":204},"Oruka Therapeutics stock price target maintained at $120 by H.C. Wainwright - Investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMizAFBVV95cUxNVVEwU2ZVVVFrZ3ByUG1DeE5iWGpCQVNoekFwYnQ3SVZGVTh2RDJaMTVNcjNEZDVDaWtmeTgzaXN4S2pOVWpzajNKQi1oWjJzc3ZjZEVTREdMTFNTLXNvSm5uQUlCZDRqZHNiU3JINm05aHhzTEFvTUhfcGlYczZOU2h2ei1peER6UDdHU3FXT0dMMG4tQmJvRVJudVFabkpSeFNSV05sYU9Vdk1JeDY4WnZyeG1XaWphajR1YmZ6YmpEMkVEV2ZvU2g0NjE?oc=5","Oruka Therapeutics stock price target maintained at $120 by H.C. Wainwright Investing.com","Investing.com",{"title":206,"link":207,"pubDate":208,"description":209,"source":210},"Oruka Therapeutics (ORKA) CEO Lawrence Klein Sells 25,000 Shares - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiogFBVV95cUxNWGxQZWxBNlZETEZLNHBleGVOZW9NZ2MxS1lySVJGbVB6QTVEYU8wOEZWQU1ucC1lamV1cF9vYTl5Mnp4NWZjVE1CeVgyc1F1NVJhdU1HNG0tb2R4bW82NjFHbTNrZWhGcXUzZi1lYjNEcFNBanZqaHBMZTZIYXlNVnNtSDdKUDlhWXYyWkEwQkNRLWxtYnM3dG9HWnlQRWtnZGc?oc=5","Sat, 03 Oct 2026 02:36:46 GMT","Oruka Therapeutics (ORKA) CEO Lawrence Klein Sells 25,000 Shares GuruFocus","GuruFocus",{"title":212,"link":213,"pubDate":179,"description":214,"source":215},"RDW vs. PL: Which Satellite Stock Has the Stronger Investment Case? - Zacks Investment Research","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqAFBVV95cUxPa0oxQVN6TVZncmU5XzRPaklIelZNbTRjR09ncXZqZE1UNUM3N20tcmt2b2stSGUtaWljN3pFYnZ5a19BLVRRdEJNcEZaR2dpUjFyY0R0aFNwTEJRdENBckdyMkF5aklwMjctYXByTzFWSDA4YnM4Z1dVYnd0bGluSDd4c3RsRUJsc0taQ3lVeUl6eVlReGVsRnZuZDRjNEYzWXlrTHFCaUg?oc=5","RDW vs. PL: Which Satellite Stock Has the Stronger Investment Case? Zacks Investment Research","Zacks Investment Research",{"title":217,"link":218,"pubDate":219,"description":220,"source":221},"Oruka Therapeutics: Review Of 28-Week Results Of ORKA-001, Q4 Data Previews (NASDAQ:ORKA) - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi2gFBVV95cUxQZ0E0Y2w2c1Rpc2ZyUEtoV25CZVY0V2ppSXZUNmg0Sm5vT05oRkFydHc3b0RvOWRVZ2RZbkFPbTltdWEwWVdfRlNSYjBHc25IOUZTc3hLdU9jUlB3OGc5SzQtOHM1Wjl2bHBZZ3FJMzgwZ2c2ajRkZUdxYjZWYlBmQjhxMmlCTGZSa3NZT0ROa1BRVzVWOTJ4T1VrRjB2TnFzZUxNX051cXkzZ0FaTm1YZnJOVWdUQ2llOGtZYlRfUWdaWm9LdE5FR3E5UGVHM1BFTF9zU09xOHlvUQ?oc=5","Thu, 24 Sep 2026 20:15:01 GMT","Oruka Therapeutics: Review Of 28-Week Results Of ORKA-001, Q4 Data Previews (NASDAQ:ORKA) Seeking Alpha","Seeking Alpha",{"title":223,"link":224,"pubDate":225,"description":226,"source":193},"Oruka Therapeutics (ORKA) Just Gave Investors A Fresh Question - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Sat, 03 Oct 2026 11:03:32 GMT","Oruka Therapeutics (ORKA) Just Gave Investors A Fresh Question Simply Wall Street",{"title":228,"link":229,"pubDate":230,"description":231,"source":204},"Oruka Therapeutics CEO Klein sells $2.09m in stock - Investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiswFBVV95cUxPVDNRd1Q5UWJQNzdEOEZYcVNJb1cweTVMWnF5Q3l6cEg5Y0NlOGRDVmtrbTBWd2xSSE45Z2N2ODN4Tkd6dTFqTlMzSzNBOEoxVWF4cFJWVTF2TmxxMXZtMXBuemo1NE8tRjVKN0tEQ3BvUVJEVnUyaHM4bF9qalo2VDNNbUxXRm9MNl9VdkQ2TzV4WFVIeU40UXJROE1CSkpOYlV4QjhBTTZsSkt4ZW8xRUNwNA?oc=5","Sat, 03 Oct 2026 02:16:42 GMT","Oruka Therapeutics CEO Klein sells $2.09m in stock Investing.com",{"title":233,"link":234,"pubDate":235,"description":236,"source":237},"Piper Sandler reiterates Oruka Therapeutics stock rating on pipeline catalysts - Investing.com UK","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi1gFBVV95cUxQbHJMcnV3VXBwZEVDVXktR0JfTERleGR1blBtTUZ1c3ZnejVrQ1JvVDZ3WXVrMVYyZjFXVGQwaU42UUc5TXVabDZrSDlqUTJoSTB0T1pDSUpMa0ZtTVhubl9YM2VtZ2dpbWdsR2JvUjk4bzFrakRFU3BpYlZDUjdZUUZqSldnUzI4YkZYLXVYMWpVZTFvOWtyUmh0RzNKOEtNVktKdHZDYi1JaURpN252SXJuQ211YUxLTG5VdjdheUFTR2g0aERnS1Y2LTE5SHZNQWNiZWd3?oc=5","Wed, 07 Oct 2026 14:08:00 GMT","Piper Sandler reiterates Oruka Therapeutics stock rating on pipeline catalysts Investing.com UK","Investing.com UK",{"title":239,"link":240,"pubDate":241,"description":242,"source":243},"Oruka Therapeutics Stock Stumbles After Hot Data Fade - TipRanks","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMilwFBVV95cUxQemw4S0JyME5kY1VvVmltZ3U0cVhzQkE5bERINE02bXN1VUJieWtTWmpncEdGWlZycFBydmxPdnQzZUJXckpxMUlCVkI0cnZHOXM5dkpDRWRlcndpQUd6UUhTN3FJTDIwOUVUNVZUT1hELW9vaWFyS3VUUVViNHhHOW1WcllrbkJOMmVGemV5N3hqX3RyQW9B?oc=5","Tue, 06 Oct 2026 14:38:43 GMT","Oruka Therapeutics Stock Stumbles After Hot Data Fade TipRanks","TipRanks",{"title":245,"link":246,"pubDate":247,"description":248,"source":243},"Oruka Therapeutics Tumbles As Biotech Rally Unravels - TipRanks","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMilgFBVV95cUxQd2VSQVl6V1duU21YdVAtTXVnT1RCdDNCQV9hVUprLTlPZFlsY3VkcXJOVGRwSEdEYzhSUExNSjlBNGRRem5md2V3RDdkc05uRFQxVGJtcWJQdFd0b3UyMm1JeGp0dnZBdmhhdUU0bXVLY1FuaG03bEJBVXVvM2xOQmhrbnRXNGVQeXpwS19BeThwMEY3SkE?oc=5","Wed, 07 Oct 2026 21:47:22 GMT","Oruka Therapeutics Tumbles As Biotech Rally Unravels TipRanks"]